MGC Pharmaceuticals has established a distribution agreement to produce and supply its cannabis based medicines to Anden Bio Naturals, giving the ASX listed company access to South American networks containing over 7,500 pharmacies, private clinics and an oncological private insurance system that has over one million listed clients. MGC’s pharmaceutical-grade phytocannabinoid products are emerging as an alternative to conventional drugs.
28/01/2020 - 15:37
MGC to distribute medical cannabis in South America
By Matt Birney
28/01/2020 - 15:37
Related Data & Insights
-
-
Rank Company Revenue th Argent BioPharma $1.7m 201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
01 Dec 2023
Board Moves December 1, 2023
28 Jul 2023
Board Moves July 28, 2023
30 Jun 2023
MGC Pharma sacks senior staffer
07 Jun 2023
Board Moves May 31 to June 2, 2023
01 Mar 2023
Board Moves March 1, 2023
03 Jan 2023
Board Moves January 3, 2023
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX